Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4724 (MIR4724) is a human microRNA gene that encodes a short, non-coding RNA molecule typically 21-23 nucleotides in length. Like other microRNAs, MIR4724 is transcribed as a primary transcript (pri-miRNA), processed to a precursor (pre-miRNA) and then to a mature form by the enzymes DROSHA and DICER. Mature microRNAs associate with Argonaute proteins in the RNA-induced silencing complex (RISC) to bind target mRNA, primarily in the 3' untranslated regions. This leads to repression of protein translation and/or mRNA destabilization[1][3][4]. Although the biological functions of most microRNAs include regulation of gene networks involved in development, differentiation, apoptosis, and disease, the specific targets, roles, or clinical significance of microRNA 4724 have not been defined in current literature.
Not applicable. For microRNAs in general, modulation occurs through inhibition of miRNA maturation or via antisense oligonucleotides but not in a drug-target sense for MIR4724 specifically[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4724 (MIR4724).